-
Pharmaceutical giants including AstraZeneca, GlaxoSmithKline and J&J race to develop a coronavirus vaccine. Blackstone Group and Global Infrastructure Partners reportedly offer to buy railroad operator Kansas City Southern. Roark buys ServiceMaster Brands.September 3
-
Mergers & Acquisitions explores 5 ways the coronavirus is changing dealmaking, as pharmaceutical companies scramble to develop vaccines, diagnostic tools and treatments.August 31
-
With the pandemic spreading, pharmaceutical manufacturers, such as Merck and Novavax, are buying biotech companies to ramp up Covid-19 research.July 14
-
Pfizer merges Lipitor and Viagra brands with Mylan. HGGC buys Monotype. Thoma Bravo acquires J.D. Power.August 2
-
Mergers & Acquisitions named 10 dealmakers the 2019 Rising Stars of Private Equity, including Summit Partners' Sophia Popova. Pfizer merges Lipitor and Viagra brands with Mylan. More deal news from Exact Sciences, Alpine.July 29
-
The generic-drug industry has been under increasing pressure in recent years as competition drives prices lower and lower.July 29
-
Pfizer purchases Array Biopharam. BidFair acquires Sotheby's. Sekisui buys Aim Aerospace from Liberty Hall.June 21
-
ma daily leadSekisui buys Aim Aeropace from Liberty Hall. Pfizer expands cancer treatments with acquisition. Altice founder Patrick Drahi buys Sotheby's.June 17
-
The deal is Pfizer’s biggest since its 2016 acquisition of Medivation, as cancer-related M&A picks up.June 17
-
Medidata’s software analyzes pharmaceutical and biotech trials for some of the world’s biggest drugmakers including Sanofi, Pfizer, and AstraZeneca.June 12
